Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders
EJC Skin Cancer · 2024
DOI: 10.1016/j.ejcskn.2023.100014 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2024. Verfasst von Alexander van Akkooi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Akkooi, A. V., Astratinei, V., Elst, K. V., & Steuten, L. (2024). Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders. EJC Skin Cancer. https://doi.org/10.1016/j.ejcskn.2023.100014
Vancouver
Akkooi AV, Astratinei V, Elst KV, Steuten L. Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders. EJC Skin Cancer. 2024. doi:10.1016/j.ejcskn.2023.100014
BibTeX
@article{Akkooi2024,
author = {Akkooi, Alexander van and Astratinei, Violeta and Elst, Koen van and Steuten, Lotte},
title = {Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders},
journal = {EJC Skin Cancer},
year = {2024},
doi = {10.1016/j.ejcskn.2023.100014}
}
EUVIMED